Related Experiment Video
Updated: May 31, 2026
12:56
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
Published on: December 19, 2017
Optogenetic approaches to restoring visual function in retinitis pigmentosa.
Volker Busskamp1, Botond Roska
1Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Current Opinion in Neurobiology
|June 29, 2011
Summary
Gene therapy using optogenetic sensors can restore vision in retinitis pigmentosa by creating artificial photoreceptors. This approach leverages microbial light-gated channels to re-enable visual function in affected retinas.
Area of Science:
- Ophthalmology
- Neuroscience
- Genetics
Background:
- Retinitis pigmentosa is an inherited condition causing photoreceptor degeneration and blindness.
- Optogenetics, inspired by microbial light-gated channels, offers a novel therapeutic avenue.
- Gene therapy aims to restore vision by introducing artificial photoreceptors.
Purpose of the Study:
- To review recent studies on optogenetic approaches for retinitis pigmentosa.
- To explore the restoration of visual activity using engineered retinal circuits.
- To discuss the translational potential of optogenetic gene therapy.
Main Methods:
- Review of animal models of retinitis pigmentosa.
- Integration of knowledge on retinal cell types, circuits, and computations.
- Application of optogenetic sensors to remaining retinal cells via gene therapy.
Main Results:
- Successful restoration of visual activity in animal models.
- Demonstration of engineered retinal circuits functioning as artificial photoreceptors.
- Evidence supporting the feasibility of optogenetic therapy.
Conclusions:
- Optogenetic gene therapy shows promise for treating retinitis pigmentosa.
- Restoring visual function requires understanding retinal circuitry and computation.
- Further research is needed to translate these findings to human patients.
